What is the maximum recommended dose of mirtazapine in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum Dose of Mirtazapine

The maximum recommended dose of mirtazapine is 45 mg per day, administered as a single daily dose preferably in the evening. 1

FDA-Approved Dosing Guidelines

  • Start at 15 mg once daily in the evening prior to sleep. 1
  • Titrate up to a maximum of 45 mg per day if patients do not have adequate response to the initial 15 mg dose. 1
  • Allow 1 to 2 weeks between dose changes to permit sufficient time for evaluation of response to a given dose. 1

Important Clinical Context About Dosing Above 45 mg

While the FDA-approved maximum is 45 mg/day, clinicians often use doses above this regulatory-defined maximum in order to attain optimal efficacy in real-world practice. 2 This reflects a recognized limitation of the approved dose range for mirtazapine. 2

  • Research studies have safely used mirtazapine at doses up to 60 mg/day, with one comparative trial using a dose range of 15-60 mg/day. 3
  • Historical pharmacokinetic data indicates mirtazapine shows linear pharmacokinetics over a dose range of 15 to 80 mg/day. 4, 5
  • However, you should adhere to the FDA-approved maximum of 45 mg/day unless there is compelling clinical justification to exceed this dose, as higher doses are off-label.

Dose Modifications Required for Drug Interactions

  • Decrease mirtazapine dose when co-administered with strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) or cimetidine. 1
  • Increase mirtazapine dose when co-administered with strong CYP3A inducers (e.g., carbamazepine, phenytoin, rifampin). 1
  • Conversely, adjust doses in the opposite direction if these interacting medications are discontinued. 1

Special Populations

  • Elderly patients and those with hepatic or renal impairment may require lower doses due to reduced clearance (approximately 30% decrease with moderate impairment, 50% decrease with severe renal impairment). 5
  • Females show higher plasma concentrations than males at equivalent doses due to pharmacokinetic differences. 5

Common Pitfall to Avoid

Do not increase the dose too rapidly. The therapeutic effect may require up to 6 weeks to become fully apparent, and dose changes should not occur more frequently than every 1-2 weeks. 1, 6 Premature dose escalation increases the risk of adverse effects without allowing adequate time to assess efficacy at the current dose.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.